Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableUnknownNCT01506258
What this trial is testing

Autologous Stem Cells in Newborns With Oxygen Deprivation

Who this might be right for
Apgar; 0-3 at 1 MinuteMetabolic AcidosisHypoxia, Brain+1 more
Hospital Universitario Dr. Jose E. Gonzalez 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07112430
What this trial is testing

Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants

Who this might be right for
Neonatal PainRetinopathy of Prematurity (ROP)Pain Management+6 more
Marsha Campbell-Yeo 58
Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Not applicableNot Yet RecruitingNCT07707219
What this trial is testing

Taste- and Olfactory-Evoked Potentials in Patients With Visual Impairment: Taste, Smell, and Vision

Who this might be right for
Central Visual ImpairmentPeripherical Visual ImpairmentMacular Retinal Dystrophy+1 more
Centre Hospitalier Universitaire Dijon 50
Not applicableStudy completedNCT01080898
What this trial is testing

Evaluation of Optical Coherence Tomography.

Who this might be right for
Age-Related Macular DegenerationChoroidal Vessels; Anastomosis
Assistance Publique - Hôpitaux de Paris 151
Not applicableStudy completedNCT07312669
What this trial is testing

ROP Check Database Premature Infant Outcomes

Who this might be right for
Retinopathy of Prematurity (ROP)
Alaska Blind Child Discovery 7,070
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Large-scale testing (Phase 3)Study completedNCT00000154
What this trial is testing

Diabetic Retinopathy Vitrectomy Study (DRVS)

Who this might be right for
Diabetic RetinopathyRetinal DetachmentVitreous Hemorrhage
National Eye Institute (NEI)
Not applicableStudy completedNCT06383754
What this trial is testing

Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study

Who this might be right for
Senile CataractEpiretinal MembraneVitreous Hemorrhage
The University of Hong Kong 50
Not applicableStudy completedNCT02823600
What this trial is testing

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

Who this might be right for
Kidney Failure, ChronicEye DiseasesDiabetic Retinopathy
University of North Carolina, Chapel Hill 68
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Post-approval studies (Phase 4)Ended earlyNCT00634972
What this trial is testing

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

Who this might be right for
Retinopathy of PrematurityRetinal DetachmentBlindness
University of South Alabama 83
Not applicableLooking for participantsNCT04697095
What this trial is testing

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

Who this might be right for
Age Related Macular Degeneration
Hospices Civils de Lyon 80
Not applicableEnded earlyNCT03105609
What this trial is testing

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Center for Eye Research Australia 4
Not applicableStudy completedNCT02395757
What this trial is testing

Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)

Who this might be right for
Stage 3 Age Related Macular Degeneration (AREDS Classification)
Hospices Civils de Lyon 182
Not applicableStudy completedNCT00648687
What this trial is testing

Pain Response During Examination for Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
National Bioethics Commission of Brazil 100
Large-scale testing (Phase 3)Study completedNCT00042211
What this trial is testing

Preventing Depression in Patients With Macular Degeneration

Who this might be right for
DepressionMacular Degeneration
Thomas Jefferson University 206
Next Page